Navigation Links
Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
Date:6/15/2012

r the complete Results of the "Biomarker Screen to Identify Peripheral Artery Disease" poster, please click here.

About Vermillion
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Additional information about Vermillion can be found at www.vermillion.com.

Forward-Looking Statement
Certain matters discussed in this press release contain forward-looking statements that involve significant risks and uncertainties, including statements regarding Vermillion's plans, objectives, expectations and intentions. These forward-looking statements are based on Vermillion's current expectations. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. In order to comply with the terms of the safe harbor, Vermillion notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. Factors that could cause actual results to materially differ include but are not limited to: (1) uncertainty as to Vermillion's ability to protect and promote its proprietary technology; (2) Vermillion's lack of a lengthy track record successfully developing and commercializing diagnostic products; (3) uncertainty as to whether Vermillion will be able to obtain any required regulatory approval of its future diagnostic products; (4) uncertainty of the size of market for its existing diagnostic test
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vermillion Announces CEO Succession Plan
2. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
3. IntelligentMDx Announces CE-Marking of a new high-throughput test for Group B Streptococcus intended to improve womens health and prenatal care
4. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
5. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
6. Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Dont Damage Hearing
7. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
8. New Medical Device Study Offers Key Marketing Budget and Staffing Metrics to Promote Effective Use of Resources
9. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
10. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
11. Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014  Savant HWP, Inc., a privately held ... human safety testing of 18-MC, an experimental treatment ... of 18-MC, administered as part of a double-blind, ... American partner, was well tolerated by healthy volunteers ... develop 18-MC as a treatment for many forms ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... additions to its Scientific Advisory Board.  The new members ... Davies , PhD. Dr. Acker is a ...
(Date:9/22/2014)... September 23, 2014 , ... authorities, increasing rigor for trial master file (TMF) accessibility ... largest TMF survey to date reveals an increase in ... provide auditors with remote access to their electronic trial ... surveyed in the Veeva 2014 Paperless TMF ...
Breaking Medicine Technology:Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4
... Va., Oct. 8 Mirixa Corporation, the leader ... hiring of Cheryl Hoffer as Vice President, Pharmacy ... Pharmacy Account Management team, supporting independent and chain ... The Pharmacy Account Management team also helps expand ...
... LAKE FOREST, Ill., Oct. 8 Hospira, Inc. (NYSE: ... pharmaceuticals, today signed a Business Cooperation Agreement with South ... outlines the business terms of a future distribution agreement ... Canada for eight biogeneric products that are currently under ...
Cached Medicine Technology:Mirixa Corporation Announces Key Pharmacy Network Hire 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 3
(Date:9/23/2014)... People across Minnesota acknowledge that their surroundings ... barriers are more prominent in the state’s rural areas, ... Prevention at Blue Cross and Blue Shield of Minnesota. ... affordable food and a lack of places where people ... percent of rural Minnesotans who responded to the poll ...
(Date:9/23/2014)... Denmark (PRWEB) September 23, 2014 The ... and aggregator founded by MediaBuzz ApS, a Danish media ... The Nordic Times works with cutting-edge news, blogs, social ... local news, EU news, and news from around the ... and Viral Content – acknowledging the way that virality ...
(Date:9/23/2014)... Waterloo, ON (PRWEB) September 23, 2014 ... is now available in the Google Play Store. , ... on BlackBerry back in March of this year, gleaning ... glowing reviews online. , "Sharing contacts has never been ... contact details in only a few steps." - CrackBerry.com, ...
(Date:9/23/2014)... "Bee Towers” was featured on NewsWatch as part of ... technology gadgets and services available to consumers. Mallory Sofastaii, a ... review and shared with viewers how it can hold ... rates in the United States continue to climb. According ... tablet. , For consumers who own a tablet but ...
(Date:9/23/2014)... Pittsburgh, PA (PRWEB) September 23, 2014 ... only home-use conception assistance device on the market cleared ... prescription in stores and online at http://www.storkotc.com . ... whose dream of having a baby is delayed by ... new first step to optimize their chances to conceive. ...
Breaking Medicine News(10 mins):Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 2Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 3Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 4Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 5Health News:Launching of The Nordic Times, a new online newspaper and aggregator. 2Health News:YOUnify for Android is Now Available in the Google Play Store 2Health News:“Bee Towers”, a Floor Standing Tablet Holder by XAR Motion, was Featured on NewsWatch, a National Television Show, This Month 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 4
... MONDAY, May 9 (HealthDay News) -- Overdiagnosis and overtreatment of ... to the large increase in the use of computed tomography ... embolism (PE) is a potentially life-threatening blood clot in the ... PE and its use has grown rapidly, according to background ...
... undergoing infertility treatment is stressful, with high rates of ... designed to help women reduce stress earlier in the ... is known specifically about the impact of these therapies ... A new study published June 1 in Fertility and ...
... - Nitric oxide gas appears to directly impact the ... cell disease, Georgia Health Sciences University researchers report. ... together, forming long chains that ultimately deform red blood ... vessels and pain, said Dr. C. Alvin Head, Chairman ...
... Week (DDW) is the largest international gathering of ... gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored ... Liver Diseases, the American Gastroenterological Association (AGA) Institute, ... Society for Surgery of the Alimentary Tract, DDW ...
... May 9 (HealthDay News) -- A new study finds that homosexual ... diagnosed with and then survive a cancer, shining a light on ... not the first time that researchers have noted differences in health ... higher risk of becoming infected with HIV, while lesbians may be ...
... By Amanda Gardner HealthDay Reporter , MONDAY, May ... any worse side effects than younger people experience, new research ... predictor for mortality or major adverse events, but it did ... B. Dorman, who is slated to present the findings Monday ...
Cached Medicine News:Health News:Scan Technology Tied to Overtreatment of Clots in Lungs 2Health News:Mind/body program increases pregnancy rates in IVF treatment 2Health News:Nitric oxide impacts source of sickle cell pain crisis 2Health News:UNC research highlights at 2011 Digestive Disease Week 2Health News:Gay Men More Likely to Have Had Cancer 2Health News:Weight-Loss Surgery Seems No Riskier for Seniors 2
... Farnsworth Dichotomous testing sets are designed ... The Farnsworth D15 test is used to ... Normal. The L'Anthony Desaturated test is much ... mild deficiency from Normal. Both of ...
... test is as easy as 1-2-3: just three ... patient satisfaction with rapid information before they leave ... immediately with the appropriate therapy; no more follow-up ... NOW® Strep A Test is a rapid immunochromatographic ...
12 mm single use, reloadable laparoscopic linear stapler with titanium staples....
Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Medicine Products: